Analyse-Technique.net - Toutes les news de l'analyse technique

Categories


Tags

pfizer,and,protalix,enter,into,agreement,to,develop,and,commercialize,gauchers,disease,treatment Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
Pfizer and Protalix recently announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) in development for the potential treatment of Gaucher's disease.
2009-12-03 - PharmaceuticalOnline